30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Adial Pharmaceuticals Inc (ADIL)

Track

The most recent insider transaction occurred on September 29, 2023, with a buy of 700 shares valued at $1,918. Prior to this, significant buying activity was noted in late 2021 by executives, including the CEO. Earlier transactions in 2020 and 2021 involved both buying and selling by other insiders.
Stock chart
Ticker: ADIL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Schuyler Kevin
1 purchase — total 1,918 USD
Buy 29 Sep 2023
Value US$3,760,969.42 | Price 169.98 | Shares 26,321
Buy 30 Dec 2021
Value US$1,669,464.87 | Price 70.63 | Shares 15,030
Buy 30 Dec 2021
Value US$1,163,630.87 | Price 32.49 | Shares 27,462
Buy 30 Dec 2021
Value US$26,600.00 | Price 2.66 | Shares 10,000
Buy 30 Nov 2021
Value US$29,178.62 | Price 2.75 | Shares 10,600
Buy 29 Nov 2021
Value US$25,892.00 | Price 2.59 | Shares 10,000
Buy 26 Nov 2021
Value US$28,500.00 | Price 2.85 | Shares 10,000
Sale 4 Oct 2021
Value US$0.00 | Price 0.00 | Shares 200,000
Sale 6 Apr 2021
Value US$375,000.00 | Price 2.50 | Shares 150,000
Sale 20 Aug 2020
Value US$423,500.00 | Price 1.21 | Shares 350,000
Buy 27 Mar 2020
Value US$6,269.40 | Price 1.35 | Shares 4,644
Buy 27 Mar 2020
Value US$13,400.00 | Price 1.34 | Shares 10,000
Buy 27 Mar 2020
Value US$7,100.00 | Price 1.42 | Shares 5,000
Buy 26 Mar 2020
Value US$18,598.44 | Price 1.47 | Shares 12,652
Buy 25 Mar 2020
Value US$13,953.24 | Price 1.13 | Shares 12,348
Sale 12 Dec 2019
Value US$150,000.00 | Price 1.00 | Shares 150,000
Buy 29 Mar 2019
Value US$1,978.02 | Price 3.30 | Shares 600
Buy 29 Mar 2019
Value US$8,669.00 | Price 3.47 | Shares 2,500
Buy 29 Mar 2019
Value US$104,154.00 | Price 3.47 | Shares 30,000
Buy 28 Mar 2019
Value US$125,808.00 | Price 3.15 | Shares 40,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 7,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 1,400
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 80,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 14,000
Buy 31 Jul 2018
Value US$0.00 | Price 0.00 | Shares 90,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-03 2023-09-29 B Purchase
1.8
Schuyler Kevin
Non-Executive Director
26,321 +29.4%
169.98
US$3,760,969 		26,321 +29.4% 169.98 US$3,760,969
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
15,030 -23.7%
70.63
US$1,669,465 		15,030 -23.7% 70.63 US$1,669,465
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
27,462 -6.5%
32.49
US$1,163,631 		27,462 -6.5% 32.49 US$1,163,631
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +100.0%
2.66
US$26,600 		10,000 +100.0% 2.66 US$26,600
2021-12-01 2021-11-30 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,600 +1.1%
2.75
US$29,179 		10,600 +1.1% 2.75 US$29,179
2021-12-01 2021-11-29 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,000 +1.1%
2.59
US$25,892 		10,000 +1.1% 2.59 US$25,892
2021-11-30 2021-11-26 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +40.9%
2.85
US$28,500 		10,000 +40.9% 2.85 US$28,500
2021-10-06 2021-10-04 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
200,000
0.00
US$0 		200,000 0.00 US$0
2021-04-08 2021-04-06 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
150,000 -21.5%
2.50
US$375,000 		150,000 -21.5% 2.50 US$375,000
2020-08-24 2020-08-20 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
350,000 -99.7%
1.21
US$423,500 		350,000 -99.7% 1.21 US$423,500
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
4,644 +46.4%
1.35
US$6,269 		4,644 +46.4% 1.35 US$6,269
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +304.1%
1.34
US$13,400 		10,000 +304.1% 1.34 US$13,400
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
5,000 +50.0%
1.42
US$7,100 		5,000 +50.0% 1.42 US$7,100
2020-03-27 2020-03-26 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,652 +1.8%
1.47
US$18,598 		12,652 +1.8% 1.47 US$18,598
2020-03-27 2020-03-25 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,348 +1.8%
1.13
US$13,953 		12,348 +1.8% 1.13 US$13,953
2019-12-13 2019-12-12 S Sale Johnson Bankole A.

Chief Medical Officer

Officer Large shareholder
150,000 -17.7%
1.00
US$150,000 		150,000 -17.7% 1.00 US$150,000
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
600 +0.2%
3.30
US$1,978 		600 +0.2% 3.30 US$1,978
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
2,500 +0.7%
3.47
US$8,669 		2,500 +0.7% 3.47 US$8,669
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
30,000 +9.5%
3.47
US$104,154 		30,000 +9.5% 3.47 US$104,154
2019-04-01 2019-03-28 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
40,000 +14.6%
3.15
US$125,808 		40,000 +14.6% 3.15 US$125,808
2018-08-02 2018-07-31 B Purchase Goodman Tony Non-Executive Director
7,000
0.00
US$0 		7,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Johnson Bankole A. Non-Executive Director Large shareholder
1,400
0.00
US$0 		1,400 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
80,000
0.00
US$0 		80,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Gilliland Robertson H. Non-Executive Director
14,000
0.00
US$0 		14,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Schuyler Kevin Non-Executive Director
90,000
0.00
US$0 		90,000 0.00 US$0
Explore more

More insider trading research around Adial Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America